Becton Dickinson

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Becton Dickinson 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About BDX

Becton, Dickinson & Co. is a global medical technology company, which engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. It operates through the following segments: BD Medical, BD Life Sciences, and BD Interventional. 

CEO
Thomas E. Polen
CEOThomas E. Polen
Employees
72,000
Employees72,000
Headquarters
Franklin Lakes, New Jersey
HeadquartersFranklin Lakes, New Jersey
Founded
1897
Founded1897
Employees
72,000
Employees72,000

BDX Key Statistics

Market cap
56.03B
Market cap56.03B
Price-Earnings ratio
33.72
Price-Earnings ratio33.72
Dividend yield
2.12%
Dividend yield2.12%
Average volume
2.48M
Average volume2.48M
High today
$196.71
High today$196.71
Low today
$195.32
Low today$195.32
Open price
$196.61
Open price$196.61
Volume
334.03K
Volume334.03K
52 Week high
$251.99
52 Week high$251.99
52 Week low
$162.29
52 Week low$162.29

Stock Snapshot

As of today, Becton Dickinson(BDX) shares are valued at $196.15. The company's market cap stands at 56.03B, with a P/E ratio of 33.72 and a dividend yield of 2.1%.

On 2025-12-25, Becton Dickinson(BDX) stock traded between a low of $195.32 and a high of $196.71. Shares are currently priced at $196.15, which is +0.4% above the low and -0.3% below the high.

The Becton Dickinson(BDX)'s current trading volume is 334.03K, compared to an average daily volume of 2.48M.

During the past year, Becton Dickinson(BDX) stock moved between $162.29 at its lowest and $251.99 at its peak.

During the past year, Becton Dickinson(BDX) stock moved between $162.29 at its lowest and $251.99 at its peak.

BDX News

Nasdaq 1d
Are Options Traders Betting on a Big Move in BD Stock?

Investors in Becton, Dickinson and Company BDX need to pay close attention to the stock based on moves in the options market lately. That is because the Jan 16,...

Are Options Traders Betting on a Big Move in BD Stock?
Benzinga 2d
Small Medtech TELA Bio Takes On Becton Dickinson, Alleges Hernia Mesh Monopoly

Becton, Dickinson & Company (NYSE:BDX) is facing allegations that it abused monopoly power in the U.S. hernia mesh market to block competition, raise costs for...

Reuters 3d
Medical device maker Becton Dickinson sued over alleged hernia mesh monopoly - Reuters

...

Medical device maker Becton Dickinson sued over alleged hernia mesh monopoly - Reuters

Analyst ratings

69%

of 16 ratings
Buy
31.3%
Hold
68.8%
Sell
0%

More BDX News

Simply Wall St 5d
Becton Dickinson: Revisiting Valuation After Recent Share Price Rebound

Becton Dickinson (BDX) has quietly outperformed the broader healthcare space over the past 3 months, even as its share price is still down year to date, which c...

Becton Dickinson: Revisiting Valuation After Recent Share Price Rebound

People also own

Based on the portfolios of people who own BDX. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.